AstraZeneca in the NEWS
Cornerstone of investment is a proposed new multi-billion dollar drug substance manufacturing center focused on chronic diseases in the Commonwealth of Virginia, the Company’s largest single Investment will support AstraZeneca’s ambition to reach $80 billion revenue by 2030, with 50% investment in a facility to date

AstraZeneca (AZN) announces $50 billions of investment in the . . .